| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| 99213 |
Office or other outpatient visit for the evaluation and management of an established patient, low complexity |
48,286 |
41,305 |
$2.62M |
| 99391 |
Periodic comprehensive preventive medicine reevaluation, established patient, infant (under 1 year) |
25,594 |
21,829 |
$2.04M |
| 99392 |
Periodic comprehensive preventive medicine reevaluation, established patient, early childhood (1-4 years) |
18,996 |
16,824 |
$1.57M |
| 99214 |
Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity |
12,836 |
10,886 |
$953K |
| 90471 |
Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine |
43,876 |
38,418 |
$795K |
| 90472 |
Immunization administration, each additional vaccine (list separately) |
29,954 |
26,315 |
$512K |
| 99393 |
Periodic comprehensive preventive medicine reevaluation, established patient, late childhood (5-11 years) |
5,416 |
4,851 |
$435K |
| 99460 |
|
2,664 |
2,307 |
$189K |
| 99394 |
Periodic comprehensive preventive medicine reevaluation, established patient, adolescent (12-17 years) |
1,561 |
1,407 |
$138K |
| 99238 |
Hospital discharge day management, 30 minutes or less |
1,901 |
1,671 |
$105K |
| 87502 |
Infectious agent detection by nucleic acid, influenza virus, for multiple types or subtypes, includes all targets |
2,214 |
1,882 |
$101K |
| 87635 |
Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe |
1,446 |
1,265 |
$52K |
| 90474 |
|
4,039 |
3,642 |
$38K |
| 87651 |
Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe |
1,536 |
1,307 |
$27K |
| G0447 |
Face-to-face behavioral counseling for obesity, 15 minutes |
1,342 |
1,266 |
$26K |
| 99212 |
Office or other outpatient visit for the evaluation and management of an established patient, straightforward |
800 |
646 |
$23K |
| 36416 |
|
5,704 |
4,710 |
$19K |
| 99239 |
Hospital discharge day management, more than 30 minutes |
197 |
168 |
$16K |
| 96110 |
Developmental screening, with scoring and documentation, per standardized instrument |
2,100 |
1,886 |
$15K |
| 99211 |
Office or other outpatient visit for the evaluation and management of an established patient, minimal severity |
1,759 |
1,549 |
$14K |
| 94760 |
|
5,804 |
5,054 |
$10K |
| 96161 |
|
4,381 |
3,577 |
$8K |
| 99463 |
|
60 |
52 |
$6K |
| 99383 |
|
28 |
28 |
$3K |
| 99462 |
|
69 |
50 |
$2K |
| 81002 |
|
1,591 |
1,427 |
$2K |
| 99381 |
|
13 |
13 |
$1K |
| 96112 |
|
15 |
12 |
$1K |
| 90686 |
|
9,609 |
8,216 |
$1K |
| 94640 |
Pressurized or nonpressurized inhalation treatment for acute airway obstruction |
93 |
71 |
$718.49 |
| 85018 |
|
383 |
337 |
$563.04 |
| 87880 |
Infectious agent antigen detection by immunoassay; Streptococcus, group A |
45 |
43 |
$371.31 |
| 90677 |
|
1,699 |
1,535 |
$267.21 |
| 90723 |
|
11,386 |
10,168 |
$242.27 |
| 90670 |
|
14,773 |
13,137 |
$170.76 |
| A7003 |
Administration set, with small volume nonfiltered pneumatic nebulizer, disposable |
96 |
73 |
$96.42 |
| 90707 |
|
3,891 |
3,463 |
$77.11 |
| 90633 |
|
4,750 |
4,200 |
$66.68 |
| 90716 |
|
3,769 |
3,353 |
$55.28 |
| 94664 |
|
35 |
27 |
$46.29 |
| 90681 |
|
4,319 |
3,887 |
$33.04 |
| J7613 |
Albuterol, inhalation solution, fda-approved final product, non-compounded, administered through dme, unit dose, 1 mg |
93 |
71 |
$5.82 |
| 90651 |
|
375 |
350 |
$0.35 |
| 99000 |
|
4,277 |
3,575 |
$0.13 |
| 90647 |
|
11,324 |
10,046 |
$0.06 |
| 90734 |
|
506 |
480 |
$0.05 |
| 90620 |
|
14 |
13 |
$0.04 |
| 90715 |
|
120 |
111 |
$0.02 |
| 90696 |
|
232 |
201 |
$0.01 |
| 90685 |
|
34 |
32 |
$0.00 |
| 99072 |
|
155 |
130 |
$0.00 |
| 90700 |
|
368 |
347 |
$0.00 |
| 99051 |
|
137 |
124 |
$0.00 |
| 90656 |
|
353 |
343 |
$0.00 |